ArticleJournal for immunotherapy of cancer2025

Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma.

Thomas Eigentler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.